Rigidity-tunable ligand-modified hybrid lipid nanoparticles target CTC-like tumor cells to suppress cancer stemness and metastasis

Abstract Circulating tumor cells (CTCs) play a critical role in tumor metastasis, and CTCs often exhibit enhanced cancer stem cell-like properties and greater metastatic potential. Therefore, developing nanodelivery systems capable of targeting CTC-like tumor cell subpopulations, stable drug delivery, and suppression of tumor stemness is of great importance for limiting metastatic progression. In this study, a chitosan-coated hybrid lipid nanoparticle system was constructed to achieve synergistic regulation of CTC-associated metastatic processes through modulation of nanoparticle rigidity, ligand-mediated recognition, and anti-stemness activity. Specifically, N-isopropylacrylamide and N-isopropylmethacrylamide were introduced onto the chitosan backbone to synthesize a CS-graft-poly (N-isopropylacrylamide-co-N-isopropylmethacrylamide) polymer (CAM), which enhanced the structural rigidity of the nanoparticles and improved their stability during blood circulation. Meanwhile, folic acid (FA)-modified chitosan shells enabled selective recognition and stable binding to folate receptor (FR)-overexpressing CTC-like tumor cells under circulation conditions. On this basis, β-elemene (β-ELE) was loaded into CAM-coated hybrid lipid nanoparticles (CAMPs) to target cancer stemness–related signaling pathways, thereby reducing stemness-associated features of tumor cells and suppressing their metastatic potential. Through the synergistic integration of rigidity regulation, ligand-targeted recognition, and tumor stemness suppression, this nanodelivery system effectively enhances preferential interaction with CTC-like tumor cell and mitigates metastasis-associated progression. Graphical abstract

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-11-16
DOI
https://doi.org/10.1186/s12951-026-05253-w
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Rigidity-tunable ligand-modified hybrid lipid nanoparticles target CTC-like tumor cells to suppress cancer stemness and metastasis

莫志亚, Ruixuan Zhang, Yunfei Li, Yujiao Sun et al.
2 links
Journal of Nanobiotechnology
Nanoparticle-Based Drug Delivery
article

Rigidity-tunable ligand-modified hybrid lipid nanoparticles target CTC-like tumor cells to suppress cancer stemness and metastasis

莫志亚, Ruixuan Zhang, Yunfei Li, Yujiao Sun, Liang Liu, Shiyang Shen, Lihong Wu, Hui Fu, Hui Wang, Yingpeng Li
article en

Abstract

Abstract Circulating tumor cells (CTCs) play a critical role in tumor metastasis, and CTCs often exhibit enhanced cancer stem cell-like properties and greater metastatic potential. Therefore, developing nanodelivery systems capable of targeting CTC-like tumor cell subpopulations, stable drug delivery, and suppression of tumor stemness is of great importance for limiting metastatic progression. In this study, a chitosan-coated hybrid lipid nanoparticle system was constructed to achieve synergistic regulation of CTC-associated metastatic processes through modulation of nanoparticle rigidity, ligand-mediated recognition, and anti-stemness activity. Specifically, N-isopropylacrylamide and N-isopropylmethacrylamide were introduced onto the chitosan backbone to synthesize a CS-graft-poly (N-isopropylacrylamide-co-N-isopropylmethacrylamide) polymer (CAM), which enhanced the structural rigidity of the nanoparticles and improved their stability during blood circulation. Meanwhile, folic acid (FA)-modified chitosan shells enabled selective recognition and stable binding to folate receptor (FR)-overexpressing CTC-like tumor cells under circulation conditions. On this basis, β-elemene (β-ELE) was loaded into CAM-coated hybrid lipid nanoparticles (CAMPs) to target cancer stemness–related signaling pathways, thereby reducing stemness-associated features of tumor cells and suppressing their metastatic potential. Through the synergistic integration of rigidity regulation, ligand-targeted recognition, and tumor stemness suppression, this nanodelivery system effectively enhances preferential interaction with CTC-like tumor cell and mitigates metastasis-associated progression. Graphical abstract

Journal of Nanobiotechnology
Tianjin University of Traditional Chinese Medicine (CN), Heilongjiang University of Chinese Medicine (CN)
National Natural Science Foundation of China
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon